Spire Healthcare Group plc (LON:SPI)
London · Delayed Price · Currency is GBP · Price in GBX 230.00
-0.50 (-0.22%)
Aug 12, 2026, 9:45 AM GMT
Spire Healthcare Group Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,580 | 1,511 | 1,359 | 1,199 | 1,106 | |
Revenue Growth | 4.54% | 11.20% | 13.39% | 8.34% | 20.25% |
Cost of Revenue | 863.7 | 827.6 | 734.8 | 660.1 | 615 |
Gross Profit | 716.1 | 683.6 | 624.2 | 538.4 | 491.2 |
Selling, General & Admin | 609.8 | 587.8 | 493.8 | 13.6 | 12.3 |
Amortization of Goodwill & Intangibles | 4.1 | 4.2 | 0.6 | - | - |
Other Operating Expenses | -157.4 | -158.7 | -100 | 324.3 | 301.8 |
Operating Expenses | 570.5 | 542.3 | 497.4 | 435.8 | 411.2 |
Operating Income | 145.6 | 141.3 | 126.8 | 102.6 | 80 |
Interest Expense | -103.5 | -98.4 | -91.5 | -85.9 | -87 |
Interest & Investment Income | 1 | 0.7 | 1.4 | - | - |
Other Non Operating Income (Expenses) | 0.3 | - | - | - | - |
EBT Excluding Unusual Items | 43.4 | 43.6 | 36.7 | 16.7 | -7 |
Merger & Restructuring Charges | -21.3 | -4.3 | -4.5 | -6.3 | -1.2 |
Gain (Loss) on Sale of Investments | 3.1 | 5.8 | 3.6 | 3 | 1.1 |
Gain (Loss) on Sale of Assets | - | 5.2 | - | - | 18.8 |
Asset Writedown | -0.5 | - | - | -0.5 | - |
Legal Settlements | -1.7 | -1.7 | - | -0.3 | -12.2 |
Other Unusual Items | -4.4 | -10.3 | -3.7 | -8.7 | -1.4 |
Pretax Income | 18.6 | 38.3 | 34.6 | 3.9 | -1.9 |
Income Tax Expense | 1.4 | 12.3 | 6.7 | -4.3 | 7 |
Earnings From Continuing Operations | 17.2 | 26 | 27.9 | 8.2 | -8.9 |
Minority Interest in Earnings | -0.8 | -0.6 | -0.6 | 0.4 | -0.8 |
Net Income | 16.4 | 25.4 | 27.3 | 8.6 | -9.7 |
Net Income to Common | 16.4 | 25.4 | 27.3 | 8.6 | -9.7 |
Net Income Growth | -35.43% | -6.96% | 217.44% | - | - |
Shares Outstanding (Basic) | 400 | 403 | 404 | 403 | 401 |
Shares Outstanding (Diluted) | 405 | 411 | 413 | 412 | 401 |
Shares Change | -1.48% | -0.42% | 0.27% | 2.79% | 0.00% |
EPS (Basic) | 0.04 | 0.06 | 0.07 | 0.02 | -0.02 |
EPS (Diluted) | 0.04 | 0.06 | 0.07 | 0.02 | -0.02 |
EPS Growth | -35.48% | -6.06% | 214.30% | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 165.9 | 126.4 | 131.6 | 93.9 | 114.5 |
Free Cash Flow Per Share | 0.41 | 0.31 | 0.32 | 0.23 | 0.29 |
Dividend Per Share | 0.015 | 0.023 | 0.021 | 0.005 | - |
Dividend Growth | -34.78% | 9.52% | 320.00% | - | - |
Gross Margin | 45.33% | 45.24% | 45.93% | 44.92% | 44.40% |
Operating Margin | 9.22% | 9.35% | 9.33% | 8.56% | 7.23% |
Profit Margin | 1.04% | 1.68% | 2.01% | 0.72% | -0.88% |
Free Cash Flow Margin | 10.50% | 8.36% | 9.68% | 7.83% | 10.35% |
EBITDA | 215.3 | 210.2 | 192.5 | 166.8 | 147.4 |
EBITDA Margin | 13.63% | 13.91% | 14.16% | 13.92% | 13.33% |
D&A For EBITDA | 69.7 | 68.9 | 65.7 | 64.2 | 67.4 |
EBIT | 145.6 | 141.3 | 126.8 | 102.6 | 80 |
EBIT Margin | 9.22% | 9.35% | 9.33% | 8.56% | 7.23% |
Effective Tax Rate | 7.53% | 32.12% | 19.36% | - | - |